| Issue Date | Title | Author(s) |
| 2008-08-01 | Treating asthma means treating airway smooth muscle cells | Zuyderduyn, S; Sukkar, MB; Fust, A; Dhaliwal, S; Burgess, JK |
| 2015-10-01 | Allergen-induced IL-6 trans-signaling activates γδ T cells to promote type 2 and type 17 airway inflammation | Ullah, MA; Revez, JA; Loh, Z; Simpson, J; Zhang, V; Bain, L; Varelias, A; Rose-John, S; Blumenthal, A; Smyth, MJ; Hill, GR; Sukkar, MB; Ferreira, MAR; Phipps, S |
| 2013-09-01 | Effect of a pharmacist intervention on asthma control. A cluster randomised trial | García-Cárdenas, V; Sabater-Hernández, D; Kenny, P; Martínez-Martínez, F; Faus, MJ; Benrimoj, SI |
| 2012-03-01 | Soluble RAGE is deficient in neutrophilic asthma and COPD | Sukkar, MB; Wood, LG; Tooze, M; Simpson, JL; McDonald, VM; Gibson, PG; Wark, PAB |
| 2012-11-01 | RAGE: A new frontier in chronic airways disease | Sukkar, MB; Ullah, MA; Gan, WJ; Wark, PAB; Chung, KF; Hughes, JM; Armour, CL; Phipps, S |
| 2017-01-18 | RAGE deficiency predisposes mice to virus-induced paucigranulocytic asthma | Arikkatt, J; Ullah, MA; Short, KR; Zhang, V; Gan, WJ; Loh, Z; Werder, RB; Simpson, J; Sly, PD; Mazzone, SB; Spann, KM; Ferreira, MAR; Upham, JW; Sukkar, MB; Phipps, S |
| 2000-12-19 | GM-CSF production from human airway smooth muscle cells is potentiated by human serum | Sukkar, MB; Margaret Hughes, J; Johnson, PRA; Armour, CL |
| 2016-04-01 | Pharmacists' interventions on clinical asthma outcomes: A systematic review | Garcia-Cardenas, V; Armour, C; Benrimoj, SI; Martinez-Martinez, F; Rotta, I; Fernandez-Llimos, F |
| 2018-03-01 | Characterization of pharmacists’ interventions in asthma management: A systematic review | Crespo-Gonzalez, C; Fernandez-Llimos, F; Rotta, I; Correr, CJ; Benrimoj, SI; Garcia-Cardenas, V |
| 2017-01-01 | Testing evidence routine practice: Using an implementation framework to embed a clinically proven asthma service in Australian community pharmacy | Fuller, JM; Saini, B; Bosnic-Anticevich, S; Garcia Cardenas, V; Benrimoj, SI; Armour, C |
